Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, Canada.


Journal

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333

Informations de publication

Date de publication:
20 04 2022
Historique:
pubmed: 1 3 2022
medline: 20 4 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

Survivors of childhood, adolescent, and young adult cancer are at risk of late effects, including pulmonary and infectious complications. Whether survivors are at increased risk of COVID-19 infection and severe complications is unknown. Population-based registries in Ontario, Canada, identified all 5-year survivors of childhood cancer diagnosed age 0-17 years between 1985 and 2014, and of six common adolescent and young adult cancers diagnosed age 15-21 years between 1992 and 2012. Each survivor alive on January 1, 2020, was randomly matched by birth year, sex, and residence to 10 cancer-free population controls. Individuals were linked to population-based laboratory and health care databases to identify COVID-19 tests, vaccinations, infections, and severe outcomes (emergency department [ED] visits, hospitalizations, intensive care unit admissions, and death within 60 days). Demographic, disease, and treatment-related variables were examined as possible predictors of outcomes. Twelve thousand four hundred ten survivors were matched to 124,100 controls. Survivors were not at increased risk of receiving a positive COVID-19 test (386 [3.1%] Cancer survivors were not at increased risk of COVID-19 infections or severe sequelae. These results can inform risk-counseling of survivors and their caregivers. Further study is warranted to determine risk in older survivors, specific subsets of survivors, and that associated with novel COVID-19 variants.

Identifiants

pubmed: 35226549
doi: 10.1200/JCO.21.02592
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1281-1290

Commentaires et corrections

Type : CommentIn

Auteurs

Sumit Gupta (S)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Canada.
Cancer Research Program, ICES, Toronto, Canada.
Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, Canada.

Rinku Sutradhar (R)

Cancer Research Program, ICES, Toronto, Canada.
Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, Canada.

Sarah Alexander (S)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.

Michelle Science (M)

Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Canada.
Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Canada.

Cindy Lau (C)

Cancer Research Program, ICES, Toronto, Canada.

Chenthila Nagamuthu (C)

Cancer Research Program, ICES, Toronto, Canada.

Mohammad Agha (M)

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Pediatric Oncology Group of Ontario, Toronto, Canada.
Primary Care & Health Systems Research Program, ICES, Toronto, Canada.

Paul C Nathan (PC)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Canada.
Cancer Research Program, ICES, Toronto, Canada.
Institute for Health Policy, Evaluation and Management, University of Toronto, Toronto, Canada.

David Hodgson (D)

Pediatric Oncology Group of Ontario, Toronto, Canada.
Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH